Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study
A prospective, single-arm, non-randomized, single-center, open-label, treat and resect study following patients through surgical resection. The study is designed to evaluate the safety and feasibility of the Aliya EX System for the ablation of pulmonary lesions using pulsed electric field (PEF) energy delivery. The stu
| Condition(s) | Lung Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | A prospective, single-arm, non-randomized, single-center, open-label, treat and resect study following patients through surgical resection. The study is designed to evaluate the safety and feasibility of the Aliya EX System for the ablation of pulmonary lesions using pulsed electric field (PEF) energy delivery. The study is intended for adult patients with suspected or confirmed pulmonary malignant lesion(s) ≥1.5 cm to ≤4 cm whom are surgical candidates and have not received treatment for the index tumor in the last two years. |
| Who can participate | Inclusion Criteria: * Presence of at least one lesion in the lung measuring ≥ 1.5 cm and ≤ 4 cm diameter by computed tomography (CT) size estimate deemed suitable for PEF ablation per institutional guidelines. * High probability of malignancy as determined by the investigator. * Patient has been deemed a candidate for definitive lung tissue resection per institutional SOC. * Patient is, in the opinion of the Principal Investigator (PI), able to adhere to and undergo the PEF and surgical procedures. * Patient is able to tolerate general anesthesia. * Patient is 18 years of age or older. * Patient has provided informed consent. Exclusion Criteria: * Patient requires neoadjuvant therapy for the disease for which surgical resection is intended. * Patient is receiving concurrent cancer treatmen |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Galvanize Therapeutics, Inc. |
| Locations | Shatin, Hong Kong |
| Start date | 2026-03-13 |
| NCT ID | NCT07487064 |
| Official listing | https://clinicaltrials.gov/study/NCT07487064 |